Skip to main content
Premium Trial:

Request an Annual Quote

GE Healthcare, Decision Biomarkers


GE Healthcare this week launched its illustra GenomiPhi HY DNA Amplification Kit and the illustra GenomiPhi V2 DNA Amplification Kit, both of which it recommends for genomic DNA preparation.

According to GE, the illustra GenomiPhi kits provide a method for genomic DNA stock replenishment and for DNA preparation upstream of PCR, genotyping, array comparative genomic hybridization, and cloning applications. Both kits use GE Healthcare's Phi 29 DNA polymerase technology which is based on an isothermal method of whole genome amplification, the company said.

GE also said that the GenomiPhi HY kit is a new offering for midi-scale DNA preparation, while the GenomiPhi V2 kit replaces GE Healthcare's original GenomiPhi kit for small-scale DNA preparation.

Decision Biomarkers last week launched its 8-Plex Cytokine Max Biochip that the company claims enables drug researchers to test for eight standard biomarkers linked to several inflammatory disorders at the same time.

The company also announced the availability of its iMark Biochip for use in customizable assays.

Both biochips are used in the Avantra Q400 Biomarker Workstation, DBI's flagship multiplexed-immunoassay system, which was formerly called the MultiMark Express.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.